• Clinical science
  • Clinician

Ischemic stroke


Ischemic stroke is an acute neurologic condition caused by impaired cerebral blood flow (e.g., vascular occlusion or systemic hypoperfusion). Chronic systemic hypertension and cardiovascular disease are the most important risk factors. Clinically, ischemic stroke is characterized by the acute onset of focal neurologic deficits, which are dependent on the cerebral territory covered by the relevant vessel. A noncontrast head CT should immediately be performed to rule out intracranial hemorrhage. Revascularization of the vessels affected in ischemic strokes, for example via tissue plasminogen activator (tPA) or thrombectomy, is vital to preserving brain tissue. Secondary prevention is focused on managing modifiable risk factors (i.e., hypertension, atherosclerosis).

For more information, see overview of stroke, intracerebral hemorrhage, and subarachnoid hemorrhage.




For both ischemic and hemorrhagic strokes, age is the most important nonmodifiable risk factor and arterial hypertension is the most important modifiable risk factor!


Epidemiological data refers to the US, unless otherwise specified.



Clinical features

Subtypes and variants

Transient ischemic attack [16]

Lacunar infarct [11][17]

Infarction of the posterior limb of the internal capsule is the most common type of lacunar stroke and may manifest clinically with pure motor stroke, pure sensory stroke (rare), sensorimotor stroke, dysarthria-clumsy hand syndrome, and/or ataxic hemiparesis.

Watershed infarct [6][18]

  • Definition: border-zone infarct in the region between the territory of two major arteries that supply the brain
  • Etiology: sudden decrease in blood pressure or cessation of blood flow through both vessels → ischemia in the susceptible region between two vascular territories
  • Clinical features
    • Signs of systemic hypoperfusion (e.g., tachycardia, low blood pressure, pallor, sweating)
    • Diffuse neurologic deterioration
    • Bilateral visual loss (cortical blindness)
    • Proximal limb weakness with sparing of the face, hands, and feet


Initial evaluation

  • Determine the time of onset of symptoms: The time of stroke onset is used to determine treatment options (thrombolytic therapy).
  • Stabilize the patient if needed.
  • Check serum glucose.
  • Emergency imaging


  1. Immediate noncontrast head CT to evaluate for acute hemorrhage prior to administration of thrombolytic therapy
  2. Further choice of imaging depends on head CT findings.
    • Diffusion-weighted MRI is a more sensitive test for acute ischemia (e.g., if head CT is negative but clinical suspicion for acute stroke is high).
    • Neurovascular studies (e.g., CTA or MRA) for more specific identification of the occluded vessel

The decision to obtain further imaging should not delay the administration of thrombolytic therapy in appropriate candidates!

Noncontrast CT

Diffusion-weighted MRI

Neurovascular studies

  • CT angiography (CTA)
    • Allows identification of the exact location of the defect (in most cases)
    • Indications
      • When there is a high index of suspicion for stroke but no ischemic changes are found on noncontrast CT or MRI.
      • If the patient cannot receive tPA (e.g., outside of the time window) but may be a candidate for mechanical thrombectomy (see “Treatment” below).
  • MRI angiography (MRA): indications similar to CTA

Laboratory evaluation [19]

Immediate imaging or administration of tPA for ischemic stroke should not be delayed to obtain laboratory studies!

Additional diagnostic workup

For more information on the diagnosis of other stroke types, see diagnosis of stroke.



Patterns of necrosis in ischemic stroke [21]

Infarction of brain tissue is typically followed by liquefactive necrosis, in contrast to the coagulative necrosis seen after infarction in other organs.

Selective neuronal necrosis


  • Definition: the death of all cell types in a given region of the brain, including neurons, glial cells, and vascular cells
  • Mechanism: permanent ischemia
  • Histology: cystic lesions and loss of tissue architecture

Histologic changes in the infarcted region [21][22]

Time from start of ischemia Histologic features
12–24 hours
1–3 days
3–5 days
5–15 days
> 15 days



Reperfusion therapy

  • Goal is to prevent further tissue ischemia and irreversible infarction
  • Should be administered as soon as possible in eligible candidates (see below for specific indications)

Reperfusion therapy should not be delayed – “time is brain”! However, intracranial hemorrhage is a contraindication for reperfusion therapy and must be ruled out first.

IV thrombolytic therapy [19]

Intra-arterial thrombolysis [19]

  • Definition: intra-arterial (not intravenous) administration of a thrombolytic agent (e.g., prourokinase)
  • Indication: MCA stroke patients with onset of symptoms < 6 hours who are not eligible for IV thrombolytic therapy

Mechanical thrombectomy [19]

Blood pressure management [19]

Supportive care



Acute management checklist


We list the most important complications. The selection is not exhaustive.


The single most important treatable risk factor for secondary stroke prevention is hypertension! [12]


  • 1. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. Stroke. 2009; 40(6): pp. 2276–93. doi: 10.1161/STROKEAHA.108.192218.
  • 2. Le T, Bhushan V, Bagga H. First Aid for the USMLE Step 2 CK. McGraw-Hill ; 2009: pp. 221–222.
  • 3. Furie KL, Hakan A. Definition of transient ischemic attack. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/definition-of-transient-ischemic-attack?source=see_link. Last updated May 25, 2016. Accessed March 28, 2017.
  • 4. Cucchiara BL, Kasner SE, Wilterdink JL. Intraventricular hemorrhage. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/intraventricular-hemorrhage. Last updated August 26, 2013. Accessed June 5, 2017.
  • 5. Centers for Disease Control and Prevention. Stroke Facts. https://www.cdc.gov/stroke/facts.htm. Updated December 30, 2016. Accessed March 28, 2017.
  • 6. Caplan LR, Kasner SE, Dashe JF. Etiology, Classification, and Epidemiology of Stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/etiology-classification-and-epidemiology-of-stroke. Last updated March 14, 2017. Accessed March 28, 2017.
  • 7. Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review. Stroke. 2009; 40(4). doi: 10.1161/STROKEAHA.108.540781.
  • 8. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill Education; 2015.
  • 9. Agabegi SS, Agabegi ED. Step-Up To Medicine. Baltimore, MD, USA: Wolters Kluwer Health; 2015.
  • 10. Le T, Bhushan V, Skelley N. First Aid for the USMLE Step 2 CK. McGraw-Hill Education; 2012.
  • 11. Oliveira Filho J. Lacunar infarcts. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/lacunar-infarcts. Last updated March 9, 2017. Accessed March 28, 2017.
  • 12. Furie KL, Rost NS. Overview of secondary prevention of ischemic stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/overview-of-secondary-prevention-of-ischemic-stroke. Last updated September 1, 2016. Accessed March 28, 2017.
  • 13. Oliveira Filho J, Mullen MT. Initial assessment and management of acute stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/initial-assessment-and-management-of-acute-stroke. Last updated August 15, 2016. Accessed March 29, 2017.
  • 14. Yew KS, Cheng EM. Diagnosis of Acute Stroke. Am Fam Physician. 2015; 91(8): pp. 528–536. url: http://www.aafp.org/afp/2015/0415/p528.html.
  • 15. EC J, JL S, Jr AH, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2013; 44(3): pp. 870–947. doi: 10.1161/STR.0b013e318284056a.
  • 16. Sorensen AG, Ay H. Transient ischemic attack: definition, diagnosis, and risk stratification. Neuroimaging Clin N Am. 2011; 21(2): pp. 303–13, x. doi: 10.1016/j.nic.2011.01.013.
  • 17. Venkataraman P, Lui F. Lacunar Syndromes. StatPearls. 2018. url: https://www.ncbi.nlm.nih.gov/books/NBK534206/.
  • 18. Standring S. Gray's Anatomy: The Anatomical Basis of Clinical Practice. Elsevier Health Sciences; 2016.
  • 19. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49(3). doi: 10.1161/str.0000000000000158.
  • 20. Oliveira Filho J. Neuroimaging of acute ischemic stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/neuroimaging-of-acute-ischemic-stroke?source=see_link#H10. Last updated April 4, 2016. Accessed March 29, 2017.
  • 21. Goljan EF. Rapid Review Pathology. Philadelphia, PA: Elsevier Saunders; 2018.
  • 22. Mena H, Cadavid D, Rushing EJ. Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol. 2004; 108(6): pp. 524–530. doi: 10.1007/s00401-004-0918-z.
  • 23. Le T, Bhushan V, Bagga HS. First Aid for the USMLE Step 2 CK. McGraw-Hill Medical; 2009.
  • 24. Jauch EC. Ischemic Stroke. In: Ischemic Stroke. New York, NY: WebMD. http://emedicine.medscape.com/article/1916852-overview. Updated December 7, 2016. Accessed March 28, 2017.
  • 25. Oliveira Filho J, Samuels OB. Reperfusion therapy for acute ischemic stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/reperfusion-therapy-for-acute-ischemic-stroke. Last updated November 28, 2016. Accessed March 29, 2017.
  • 26. Goldstein LB, Bushnell CD, Adams RJ et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010; 42(2): pp. 517–584. doi: 10.1161/STR.0b013e3181fcb238.
  • 27. Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2014; 45(7): pp. 2160–2236. doi: 10.1161/STR.0000000000000024.
  • 28. Charles H Hennekens. Overview of primary prevention of coronary heart disease and stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/overview-of-primary-prevention-of-coronary-heart-disease-and-stroke?search=stroke%20primary%20prevention&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Last updated November 27, 2018. Accessed April 1, 2019.
  • 29. Furie KL, Hakan A. Initial evaluation and management of transient ischemic attack and minor ischemic stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/initial-evaluation-and-management-of-transient-ischemic-attack-and-minor-ischemic-stroke. Last updated October 27, 2016. Accessed March 29, 2017.
  • Parker S, Ali Y. Changing contraindications for t-PA in acute stroke: review of 20 years since NINDS. Curr Cardiol Rep. 2015; 17(10): p. 81. doi: 10.1007/s11886-015-0633-5.
  • Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018; 379(3): pp. 215–225. doi: 10.1056/nejmoa1800410.
  • Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke. N Engl J Med. 2015; 372(24): pp. 2296–2306. doi: 10.1056/nejmoa1503780.
  • Burgos AM, Saver JL. Evidence that Tenecteplase Is Noninferior to Alteplase for Acute Ischemic Stroke. Stroke. 2019; 50(8): pp. 2156–2162. doi: 10.1161/strokeaha.119.025080.
  • Lansberg MG, O’Donnell MJ, Khatri P, et al. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2): pp. e601S–e636S. doi: 10.1378/chest.11-2302.
  • Thomalla G, Cheng B, Ebinger M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. The Lancet Neurology. 2011; 10(11): pp. 978–986. doi: 10.1016/s1474-4422(11)70192-2.
  • Vagal A, Wintermark M, Nael K, et al. Automated CT perfusion imaging for acute ischemic stroke. Neurology. 2019: p. 10.1212/WNL.0000000000008481. doi: 10.1212/wnl.0000000000008481.
  • Copen WA, Schaefer PW, Wu O. MR Perfusion Imaging in Acute Ischemic Stroke. Neuroimaging Clin N Am. 2011; 21(2): pp. 259–283. doi: 10.1016/j.nic.2011.02.007.
  • Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. The Lancet. 2000; 355(9216): pp. 1670–1674. doi: 10.1016/s0140-6736(00)02237-6.
  • Kasner SE. Clinical interpretation and use of stroke scales. The Lancet Neurology. 2006; 5(7): pp. 603–612. doi: 10.1016/s1474-4422(06)70495-1.
  • Berkhemer OA, Fransen PSS, Beumer D, et al. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke. N Engl J Med. 2015; 372(1): pp. 11–20. doi: 10.1056/nejmoa1411587.
  • Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med. 2015; 372(11): pp. 1009–1018. doi: 10.1056/nejmoa1414792.
  • Saver JL, Goyal M, Bonafe A, et al. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke. N Engl J Med. 2015; 372(24): pp. 2285–2295. doi: 10.1056/nejmoa1415061.
  • Warren J Manning, Daniel E singer, Gregory YH Lip. Atrial fibrillation: Anticoagulant therapy to prevent thromboembolism. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/atrial-fibrillation-anticoagulant-therapy-to-prevent-thromboembolism?source=autocomplete&index=0~4&search=atrial%20fibrillation:. Last updated July 24, 2018. Accessed April 1, 2019.
  • Goyal M, Demchuk AM, Menon BK, et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med. 2015; 372(11): pp. 1019–1030. doi: 10.1056/nejmoa1414905.
  • Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005; 26(5): pp. 1012–21. pmid: 15891154.
  • Hirai T, Korogi Y, Ono K, et al. Prospective evaluation of suspected stenoocclusive disease of the intracranial artery: combined MR angiography and CT angiography compared with digital subtraction angiography. AJNR Am J Neuroradiol. 2002; 23(1): pp. 93–101. pmid: 11827880.
  • Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018; 378(8): pp. 708–718. doi: 10.1056/nejmoa1713973.
  • Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018; 378(1): pp. 11–21. doi: 10.1056/nejmoa1706442.
  • Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. N Engl J Med. 2018; 379(7): pp. 611–622. doi: 10.1056/nejmoa1804355.
  • NIHSS MD Calc. https://www.mdcalc.com/nih-stroke-scale-score-nihss. Accessed March 2, 2020.
  • Smith EE, Kent DM, Bulsara KR, et al. Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. Stroke. 2018; 49(3). doi: 10.1161/str.0000000000000160.
  • Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic Accuracy of Stroke Referrals From Primary Care, Emergency Room Physicians, and Ambulance Staff Using the Face Arm Speech Test. Stroke. 2003; 34(1): pp. 71–76. doi: 10.1161/01.str.0000044170.46643.5e.
  • Porth C, Matfin G. Pathophysiology. Lippincott Williams & Wilkins; 2009.
  • Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease. Chest. 2016; 149(2): pp. 315–352. doi: 10.1016/j.chest.2015.11.026.
  • Louis R Caplan. Overview of the Evaluation of Stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/overview-of-the-evaluation-of-stroke?search=overview%20of%20the%20evaluation%20of%20stroke&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Last updated February 14, 2019. Accessed April 1, 2019.
  • Schur PH, Kaplan AA. Treatment of antiphospholipid syndrome. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/treatment-of-antiphospholipid-syndrome. Last updated February 23, 2017. Accessed April 3, 2017.
  • Cucchiara BL, Messé SR. Antiplatelet therapy for secondary prevention of stroke. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/antiplatelet-therapy-for-secondary-prevention-of-stroke. Last updated July 25, 2016. Accessed February 20, 2017.
  • Fugate JE, Rabinstein AA. Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke. The Neurohospitalist. 2015; 5(3): pp. 110–121. doi: 10.1177/1941874415578532.
last updated 09/21/2020
{{uncollapseSections(['aZ1QZ20', 'YZ1nZ20', 'bZ1HZ20', 'XZ19Z20', 'cZ1a020', 'dZ1o020', '1Z12020', 'iZ1JY20', 'WZ1P020', 'c31ahg0', 'eZ1x020', 'VZ1G020'])}}